- Novo Nordisk's head of commercial strategy steps down
- High just got higher: Trump tariffs to raise prices for US cannabis users
- Texas Pacific Land Corp sees insider purchases totaling $13,344
- Rubio: US is committed to NATO, but Europe must spend more on defence
- November home sales surged more than expected, boosted by lower mortgage rates
- Trump Georgia election case DA Fani Willis disqualified but indictment stands: appeals court
- FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
- The Fed's rate outlook has rattled markets. Here's what it means for global central banks
- Wall Street's fear gauge — the VIX — saw second-biggest spike ever on Wednesday
- How the market pullback could get worse in January
- Malls are using new restaurants to draw consumers as shopping centers reinvent themselves
- Darden Restaurants' sales rise 6%, fueled by Olive Garden and LongHorn Steakhouse
- Bank of England holds rates but vote split surprises markets
- How Vuori reached a $5.5 billion valuation by taking share from Lululemon
